Welcome to the Symptomatic Asthma Learning Zone
This educational resource is for European healthcare professionals involved in the care of patients with asthma. The Disease Awareness section provides background information regarding the impact of symptomatic asthma and potential management strategies.
SPIRIVA® Respimat® is approved for use in asthma in the European Union, Japan, USA and many other countries. The indication varies by country and the educational resource may contain information about medications for which indications may not be approved in your country.